265 related articles for article (PubMed ID: 15039063)
21. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
[TBL] [Abstract][Full Text] [Related]
22. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
23. Screening assay for the identification of deoxyhypusine synthase inhibitors.
Sommer MN; Bevec D; Klebl B; Flicke B; Hölscher K; Freudenreich T; Hauber I; Hauber J; Mett H
J Biomol Screen; 2004 Aug; 9(5):434-8. PubMed ID: 15296643
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine.
Park MH; Wolff EC; Smit-McBride Z; Hershey JW; Folk JE
J Biol Chem; 1991 May; 266(13):7988-94. PubMed ID: 1850732
[TBL] [Abstract][Full Text] [Related]
25. Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties.
Kaiser A; Hammels I; Gottwald A; Nassar M; Zaghloul MS; Motaal BA; Hauber J; Hoerauf A
Bioorg Med Chem; 2007 Sep; 15(18):6200-7. PubMed ID: 17591443
[TBL] [Abstract][Full Text] [Related]
26. Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification.
Cano VS; Jeon GA; Johansson HE; Henderson CA; Park JH; Valentini SR; Hershey JW; Park MH
FEBS J; 2008 Jan; 275(1):44-58. PubMed ID: 18067580
[TBL] [Abstract][Full Text] [Related]
27. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine.
Joe YA; Park MH
J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297
[TBL] [Abstract][Full Text] [Related]
28. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts.
Chen ZP; Chen KY
J Cell Physiol; 1997 Mar; 170(3):248-54. PubMed ID: 9066781
[TBL] [Abstract][Full Text] [Related]
29. Reversal of the deoxyhypusine synthesis reaction. Generation of spermidine or homospermidine from deoxyhypusine by deoxyhypusine synthase.
Park JH; Wolff EC; Folk JE; Park MH
J Biol Chem; 2003 Aug; 278(35):32683-91. PubMed ID: 12788913
[TBL] [Abstract][Full Text] [Related]
30. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
31. The deoxyhypusine synthase mutant dys1-1 reveals the association of eIF5A and Asc1 with cell wall integrity.
Galvão FC; Rossi D; Silveira Wda S; Valentini SR; Zanelli CF
PLoS One; 2013; 8(4):e60140. PubMed ID: 23573236
[TBL] [Abstract][Full Text] [Related]
32. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
Park MH; Wolff EC; Folk JE
Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
[TBL] [Abstract][Full Text] [Related]
33. Characterization of yeast deoxyhypusine synthase: PKC-dependent phosphorylation in vitro and functional domain identification.
Kang KR; Chung SI
Exp Mol Med; 1999 Dec; 31(4):210-6. PubMed ID: 10630376
[TBL] [Abstract][Full Text] [Related]
34. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
35. Functional significance of eIF5A and its hypusine modification in eukaryotes.
Park MH; Nishimura K; Zanelli CF; Valentini SR
Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of a cDNA encoding functional human deoxyhypusine synthase and chromosomal mapping of the corresponding gene locus.
Bevec D; Kappel B; Jaksche H; Csonga R; Hauber J; Klier H; Steinkasserer A
FEBS Lett; 1996 Jan; 378(2):195-8. PubMed ID: 8549832
[TBL] [Abstract][Full Text] [Related]
37. Enzyme-substrate intermediate formation at lysine 329 of human deoxyhypusine synthase.
Wolff EC; Folk JE; Park MH
J Biol Chem; 1997 Jun; 272(25):15865-71. PubMed ID: 9188485
[TBL] [Abstract][Full Text] [Related]
38. Assay of deoxyhypusine hydroxylase activity.
Park JH; Wolff EC; Park MH
Methods Mol Biol; 2011; 720():207-16. PubMed ID: 21318876
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
40. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
